The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Zheleznikova G.F.

Nauchno-issledovatel'skiĭ institut detskikh infektsiĭ Federal'nogo mediko-biologicheskogo agentstva Rossii, Sankt-Peterburg

Skripchenko N.V.

Pediatric Research and Clinical Center for Infectious Diseases, Saint Petersburg, Russia

Ivanova G.P.

Moskovskiĭ nauchno-issledovatel'skiĭ institut psikhiatrii

Surovtseva A.V.

FGBU "Nauchno-issledovatel'skiĭ institut detskikh infektsiĭ", Sankt-Peterburg

Scripchenko E.Y.

St-Petersburg State Pediatric Medical University, St-Petersburg, Russia;
City Centre of Multiple Sclerosis Saint Petersburg City Clinical Hospital №31, , St-Petersburg, Russia

Gerpes viruses and multiple sclerosis

Authors:

Zheleznikova G.F., Skripchenko N.V., Ivanova G.P., Surovtseva A.V., Scripchenko E.Y.

More about the authors

Read: 10213 times


To cite this article:

Zheleznikova GF, Skripchenko NV, Ivanova GP, Surovtseva AV, Scripchenko EY. Gerpes viruses and multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(9):133‑143. (In Russ.)
https://doi.org/10.17116/jnevro201611691133-143

Recommended articles:
A clinical case of X-linked adre­noleukodystrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):102-107
Cognitive impairment in patients with multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4-2):67-73
Arti­ficial inte­lligence capa­bilities in multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):14-21
Mole­cular mechanisms of acute disseminated ence­phalomyelitis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):7-11
The role of mono­cytes in the immu­nopathogenesis of multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):23-27
Current epidemiology of MS with onset in childhood and adolescence (pediatric multiple scle­rosis). S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):34-38
Features of the clinical course of multiple scle­rosis as a factor in persistent disa­bility. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):39-44
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50

References:

  1. Gusev EI, Zavalishin IA, Bojko AN. Rassejannyj skleroz i drugie demielinizirujushhie zabolevanija. M.: Miklosh; 2004. (In Russ.).
  2. Venkatesan A, Johnson R. Infections and multiple sclerosis. Handb Clin Neurol. 2014;122:151-171.  doi: 10.1016/B978-0-444-52001-2.00007-8
  3. McCarthy D, Richards M, Miller S. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease. Methods Mol Biol. 2012;900:381-401.  doi: 10.1007/978-1-60761-720-4_19
  4. Smyk D, Alexander A, Walker M, Walker M. Acute disseminated encephalomyelitis progressing to multiple sclerosis: are infectious triggers involved? Immunol Res. 2014;60(1):16-22.  doi: 10.1007/s12026-014-8499-y
  5. Ivanova GP. Lejkojencefality u detej (differencial'no-diagnosticheskie, patogeneticheskie i terapevticheskie aspekty): Dis. ... d-ra med. nauk. SPb, 2012. Ssylka aktivna na 07.04.15. Dostupno po: http://www.dissers.ru/2meditsina/leykoencefaliti-detey-differencialno-diagnosticheskie-patogeneticheskie-terapevticheskie-aspekti-14-01-11-nervnie-bolezni-14-01-09-infekcionnie-bolezni-avtoreferat.php (In Russ.).
  6. Libbey J, Cusick M, Fujinami R. Role of pathogens in multiple sclerosis. Int Rev Immunol. 2014;33(4):266-283.  doi: 10.3109/08830185.2013.823422
  7. Zheleznikova GF. Vozdejstvie virusov na sistemu citokinov hozjaina. Voprosy virusologii. 2007;4:4-10. (In Russ.).
  8. Tselis A. Evidence for viral etiology of multiple sclerosis. Semin Neurol. 2011;31(3):307-316.  doi: 10.1055/s-0031-1287656
  9. Johnson T, Tyagi R, Patel K, Schiess N, Calabresi P, Nath A. Impaired toll-like receptor 8 signaling in multiple sclerosis. J Neuroinflammation. 2013;10:74.  doi: 10.1186/1742-2094-10-74
  10. Longhini A, von Glehn F, Brandão C, de Paula R, Pradella F, Moraes A, Farias A, Oliveira E, Quispe-Cabanillas J, Abreu C, Damasceno A, Damasceno B, Balashov K, Santos L. Plasmacytoid dendritic cells are increased in cerebrospinal fluid of untreated patients during multiple sclerosis relapse. J Neuroinflammation. 2011;8(1):2.  doi: 10.1186/1742-2094-8-2
  11. Cusick M, Libbey J, Fujinami R. Multiple sclerosis: autoimmunity and viruses. Curr Opin Rheumatol. 2013;25(4):496-501.  doi: 10.1097/BOR.0b013e328362004d
  12. Ji Q, Perchellet A, Goverman J. Viral infection triggers central nervous system autoimmunity via activation of CD8+ T cells expressing dual TCRs. Nat Immunol. 2010;11(7):628-634.  doi: 10.1038/ni.1888.
  13. Bonnan M. Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs? Front Neurol. 2014;5:27.  doi: 10.3389/fneur.2014.00027
  14. Holmøy T, Vartdal F, Hestvik AL, Munthe L, Bogen B.The idiotype connection: linking infection and multiple sclerosis. Trends Immunol. 2010;31(2):56-62.  doi: 10.1016/j.it.2009.11.001
  15. Skorstad G, Vandvik B, Vartdal F, Holmøy T. MS and clinically isolated syndromes: shared specificity but diverging clonal patterns of virus-specific IgG antibodies produced in vivo and by CSF B cells in vitro. Eur J Neurol. 2009;16(10):1124-1129. doi: 10.1111/j.1468-1331.2009.02657.x
  16. Djelilovic-Vranic J, Alajbegovic A. Role of early viral infections in development of multiple sclerosis. Med Arch. 2012;66(3 suppl 1):37-40.
  17. Sellner J, Cepok S, Kalluri S, Nestler A, Kleiter I. Aquaporin 4 antibody positive central nervous system autoimmunity and multiple sclerosis are characterized by a distinct profile of antibodies to herpes viruses. Neurochem Int. 2010;57(6):662-667.  doi: 10.1016/j.neuint.2010.08.003
  18. Lomakin Y, Zakharova M, Belogurov A, Bykova N, Dronina M, Tupikin A, Knorre V, Boyko A, Favorov A, Kabilov M, Ponomarenko N, Gabibov G. Polyreactive monoclonal autoantibodies in multiple sclerosis: functional selection from phage display library and characterization by deep sequencing analysis. Acta Naturae. 2013;5(4):94-104.
  19. Waubant E, Mowry E., Krupp L, Chitnis T, Yeh E., Kuntz N, Ness J, Chabas D, Strober J, McDonald J, Belman A, Milazzo M, Gorman M, Weinstock-Guttman B, Rodriguez M, Oksenberg J., James J. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology. 2011;76(23):1989-1995. doi: 10.1212/WNL.0b013e31821e552a
  20. Ascherio A, Munger K. Epstein-barr virus infection and multiple sclerosis: a review. J Neuroimmune Pharmacol. 2010;5(3):271-277.  doi: 10.1007/s11481-010-9201-3
  21. Gustavsen M, Page C, Moen S, Bjølgerud A, Berg-Hansen P, Nygaard G, Sandvik L, Lie B, Celius E, Harbo H. Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study. BMC Neurol. 2014;14:196.  doi: 10.1186/s12883-014-0196-x
  22. Pender M. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis. Neuroscientist. 2011;17(4):351-367.  doi: 10.1177/1073858410381531
  23. Bø L. The histopathology of grey matter demyelination in multiple sclerosis. Acta Neurol Scand Suppl. 2009;(189):51-57.  doi: 10.1111/j.1600-0404.2009.01216.x
  24. Décard B, von Ahsen N, Grunwald T, Streit F, Stroet A, Niggemeier P, Schottstedt V, Riggert J, Gold R, Chan A. Low vitamin D and elevated immunoreactivity against Epstein-Barr virus before first clinical manifestation of multiple sclerosis. J Neurol Neurosurg Psychiatry. 2012;83(12):1170-1173. doi: 10.1136/jnnp-2012-303068
  25. Lucas R, Ponsonby A, Dear K, Valery P, Pender M, Burrows J, Burrows S, Chapman C, Coulthard A, Dwyer D., Dwyer T, Kilpatrick T, Lay M, McMichael A., Taylor B. Current and past Epstein-Barr virus infection in risk of initial CNS demyelination. Neurology. 2011;77(4):371-379.  doi: 10.1212/WNL.0b013e318227062a
  26. Santiago O, Gutierrez J, Sorlozano A, de Dios Luna J, Villegas E, Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis. 2010;29(7):857-866.  doi: 10.1007/s10096-010-0940-0
  27. Abdelrahman H, Selim H, Hashish M, Sultan L. Epstein-Barr virus in multiple sclerosis. J Egypt Public Health Assoc. 2014;89(2):90-95.  doi: 10.1097/01.EPX.0000452287.65133.fc
  28. Pandit L, Malli C, D'Cunha A, Shetty R, Singhal B. Association of Epstein-Barr virus infection with multiple sclerosis in India. J Neurol Sci. 2013;325(1-2):86-89.  doi: 10.1016/j.jns.2012.12.004
  29. Franciotta D, Di Stefano A., Jarius S, Zardini E, Tavazzi E, Ballerini C, Marchioni E, Bergamaschi R, Ceroni M. Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases. J Neuroimmunol. 2011;230(1-2):160-163.  doi: 10.1016/j.jneuroim.2010.10.027
  30. Otto C, Oltmann A, Stein A, Frenzel K, Schroeter J, Habbel P, Gärtner B, Hofmann J, Ruprecht K. Intrathecal EBV antibodies are part of the polyspecific immune response in multiple sclerosis. Neurology. 2011;76(15):1316-1321. doi: 10.1212/WNL.0b013e318215286d
  31. Villegas E, Santiago O, Carrillo J., Sorlózano A, Guerrero M, Fernández O, Gutiérrez J. Low intrathecal immune response of anti-EBNA-1 antibodies and EBV DNA from multiple sclerosis patients. Diagn Microbiol Infect Dis. 2011;70(1):85-90.  doi: 10.1016/j.diagmicrobio.2010.11.013
  32. Castellazzi M, Contini C, Tamborino C, Fasolo F, Roversi G, Seraceni S, Rizzo R, Baldi E, Tola M, Bellini T, Granieri E, Fainardi E. Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies. J Neuroinflammation. 2014;11(1):188.
  33. Carter C. Epstein-Barr and other viral mimicry of autoantigens, myelin and vitamin D-related proteins and of EIF2B, the cause of vanishing white matter disease: massive mimicry of multiple sclerosis relevant proteins by the Synechococcus phage. Immunopharmacol Immunotoxicol. 2012;34(1):21-35.  doi: 10.3109/08923973.2011.572262
  34. Gabibov AG, Belogurov AA, Lomakin YA, Zakharova MY, Avakyan ME, Dubrovskaya VV, Smirnov IV, Ivanov AS, Molnar AA, Gurtsevitch VE, Diduk SV, Smirnova KV, Avalle B, Sharanova SN, Tramontano A, Friboulet A, Boyko AN, Ponomarenko NA, Tikunova NV. Combinatorial antibody library from multiple sclerosis patients reveals antibodies that cross-react with myelin basic protein and EBV antigen. FASEB J. 2011;25(12):4211-4221. doi: 10.1096/fj.11-190769
  35. Salvetti M, Giovannoni G, Aloisi F. Epstein-Barr virus and multiple sclerosis. Curr Opin Neurol. 2009;22(3):201-206.  doi: 10.1097/WCO.0b013e32832b4c8d
  36. Willis S, Stadelmann C, Rodig S, Caron T, Gattenloehner S, Mallozzi S, Roughan J, Almendinger S, Blewett M, Brück W, Hafler D, O'Connor K. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain. 2009;132(Pt 12):3318-3328. doi: 10.1093/brain/awp200
  37. Torkildsen Ø, Stansberg C, Angelskår S, Kooi E, Geurts J, van der Valk P, Myhr K, Steen V, Bø L. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol. 2010;20(4):720-729.  doi: 10.1111/j.1750-3639.2009.00343.x
  38. Sargsyan S, Shearer A, Ritchie A, Burgoon M, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens G, Gilden D, Bennett J. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology. 2010;74(14):1127-1135. doi: 10.1212/WNL.0b013e3181d865a1
  39. Cocuzza C, Piazza F, Musumeci R, Oggioni D, Andreoni S, Gardinetti M, Fusco L, Frigo M, Banfi P, Rottoli M., Rezzonico M, Ferrò M, Cavaletti G. Quantitative detection of Epstein-Barr virus DNA in cerebrospinal fluid and blood samples of patients with relapsing-remitting multiple sclerosis. PLoS One. 2014;9(4):94497. doi: 10.1371/journal.pone.0094497
  40. Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, Magliozzi R, Reynolds R, Coccia E, Aloisi F. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol. 2010;69(7):677-693.  doi: 10.1097/NEN.0b013e3181e332ec
  41. Magliozzi R, Serafini B, Rosicarelli B, Chiappetta G, Veroni C, Reynolds R, Aloisi F. B-cell enrichment and Epstein-Barr virus infection in inflammatory cortical lesions in secondary progressive multiple sclerosis. J Neuropathol Exp Neurol. 2013;72(1):29-41.  doi: 10.1097/NEN.0b013e31827bfc62
  42. Tzartos J, Khan G, Vossenkamper A, Cruz-Sadaba M, Lonardi S, Sefia E, Meager A, Elia A, Middeldorp J, Clemens M, Farrell P., Giovannoni G, Meier U. Association of innate immune activation with latent Epstein-Barr virus in active MS lesions. Neurology. 2012;78(1):15-23.  doi: 10.1212/WNL.0b013e31823ed057
  43. Tracy S, Kakalacheva K, Lünemann J, Luzuriaga K, Middeldorp J, Thorley-Lawson D. Persistence of Epstein-Barr virus in self-reactive memory B cells. J Virol. 2012;86(22):12330-12340. doi: 10.1128/JVI.01699-12
  44. Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis. Brain. 2008;131(7):1712-1721. doi: 10.1093/brain/awn108
  45. Lünemann J, Jelcić I, Roberts S, Lutterotti A, Tackenberg B, Martin R, Münz C. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med. 2008;205(8):1763-1773. doi: 10.1084/jem.20072397
  46. Comabella M, Kakalacheva K, Río J, Münz C, Montalban X, Lünemann J. EBV-specific immune responses in patients with multiple sclerosis responding to IFNβ therapy. Mult Scler. 2012;18(5):605-609.  doi: 10.1177/1352458511426816
  47. Cheng W, Ma Y, Gong F, Hu C, Qian L, Huang Q, Yu Q, Zhang J, Chen S, Liu Z, Chen X, Zhou T, Zhang D. Cross-reactivity of autoreactive T cells with MBP and viral antigens in patients with MS. Front Biosci (Landmark Ed). 2012;17:1648-1658. doi: 10.2741/4010 
  48. Angelini D, Serafini B, Piras E, Severa M, Coccia EM, Rosicarelli B, Ruggieri S, Gasperini C, Buttari F, Centonze D, Mechelli R, Salvetti M, Borsellino G, Aloisi F, Battistini L. Increased CD8+ T cell response to Epstein-Barr virus lytic antigens in the active phase of multiple sclerosis. PLoS Pathog. 2013;9(4):1003220. doi: 10.1371/journal.ppat.1003220
  49. Yea C, Tellier R, Chong P, Westmacott G, Marrie R., Bar-Or A, Banwell B. Epstein-Barr virus in oral shedding of children with multiple sclerosis. Neurology. 2013;81(16):1392-1399. doi: 10.1212/WNL.0b013e3182a841e4
  50. Jaquiery E, Jilek S, Schluep M, Le Goff G, Garcia M, Pantaleo G, Du Pasquier R. Cytokine mRNA profile of Epstein-Barr virus-stimulated highly differentiated T cells in multiple sclerosis: a pilot study. J Neuroimmunol. 2010;225(1-2):167-170.  doi: 10.1016/j.jneuroim.2010.04.011
  51. Antony J, Deslauriers A, Bhat R, Ellestad K, Power C. Human endogenous retroviruses and multiple sclerosis: innocent bystanders or disease determinants? Biochim Biophys Acta. 2011;1812(2):162-176.  doi: 10.1016/j.bbadis.2010.07.016
  52. Perron H, Germi R, Bernard C, Garcia-Montojo M, Deluen C, Farinelli L, Faucard R, Veas F, Stefas I, Fabriek B., Van-Horssen J, Van-der-Valk P, Gerdil C, Mancuso R, Saresella M, Clerici M, Marcel S, Creange A, Cavaretta R, Caputo D, Arru G, Morand P, Lang AB, Sotgiu S, Ruprecht K, Rieckmann P, Villoslada P, Chofflon M, Boucraut J, Pelletier J, Hartung H. Human endogenous retrovirus type W envelope expression in blood and brain cells provides new insights into multiple sclerosis disease. Mult Scler. 2012;18(12):1721-1736. doi: 10.1177/1352458512441381
  53. Saresella M, Rolland A, Marventano I, Cavarretta R, Caputo D, Marche P, Perron H, Clerici M. Multiple sclerosis-associated retroviral agent (MSRV)-stimulated cytokine production in patients with relapsing-remitting multiple sclerosis. Mult Scler. 2009;15(4):443-447.  doi: 10.1177/1352458508100840
  54. Mameli G, Poddighe L, Mei A, Uleri E, Sotgiu S, Serra C, Manetti R, Dolei A. Expression and activation by Epstein Barr virus of human endogenous retroviruses-W in blood cells and astrocytes: inference for multiple sclerosis. PLoS One. 2012;7(9):44991. doi: 10.1371/journal.pone.0044991
  55. Mameli G, Madeddu G, Mei A, Uleri E, Poddighe L, Delogu L, Maida I, Babudieri S, Serra C, Manetti R, Mura M, Dolei A. Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? PLoS One. 2013;8(11):78474. doi: 10.1371/journal.pone.0078474
  56. Voumvourakis K, Kitsos D, Tsiodras S, Petrikkos G, Stamboulis E. Human herpesvirus 6 infection as a trigger of multiple sclerosis. Mayo Clin Proc. 2010;85(11):1023-1030. doi: 10.4065/mcp.2010.0350
  57. Simpson S, Taylor B, Dwyer D, Taylor J, Blizzard L, Ponsonby A, Pittas F, Dwyer T, van der Mei I. Anti-HHV-6 IgG titer significantly predicts subsequent relapse risk in multiple sclerosis. Mult Scler. 2012;18(6):799-806.  doi: 10.1177/1352458511428081
  58. Ben-Fredj N, Ben-Selma W, Rotola A, Nefzi F, Benedetti S, Frih-Ayed M, Di Luca D, Aouni M, Caselli E. Prevalence of human herpesvirus U94/REP antibodies and DNA in Tunisian multiple sclerosis patients. J Neurovirol. 2013;19(1):42-47.  doi: 10.1007/s13365-012-0138-6
  59. Nora-Krukle Z, Chapenko S, Logina I, Millers A, Platkajis A, Murovska M. Human herpesvirus 6 and 7 reactivation and disease activity in multiple sclerosis. Medicina (Kaunas). 2011;47(10):527-531.
  60. Garcia-Montojo M, De Las Heras V, Dominguez-Mozo M, Bartolome M, Garcia-Martinez M, Arroyo R, Alvarez-Lafuente R. Human herpesvirus 6 and effectiveness of interferon β1b in multiple sclerosis patients. Eur J Neurol. 2011;18(8):1027-1035. doi: 10.1111/j.1468-1331.2011.03410.x
  61. Alvarez-Lafuente R, Martinez A, Garcia-Montojo M, Mas A, De Las Heras V, Dominguez-Mozo M, Maria Del Carmen C, López-Cavanillas M, Bartolome M, Gomez de la Concha E, Urcelay E, Arroyo R. MHC2TA rs4774C and HHV-6A active replication in multiple sclerosis patients. Eur J Neurol. 2010;17(1):129-135.  doi: 10.1111/j.1468-1331.2009.02758.x
  62. Dominguez-Mozo M, Garcia-Montojo M, De Las Heras V, Garcia-Martinez A, Arias-Leal A, Casanova I, Arroyo R, Alvarez-Lafuente R. MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up. BMC Neurol. 2012;12:107.  doi: 10.1186/1471-2377-12-107
  63. Ivanova GP, Skripchenko NV, Zheleznikova GF, Monahova NE. Osobennosti immunnoj zashhity pri lejkojencefalitah u detej. Rossijskij vestnik Perinatol Pediatr. 2012;3:56-64. (In Russ.).
  64. Brudek T, Lühdorf P, Christensen T, Hansen H, Møller-Larsen A. Activation of endogenous retrovirus reverse transcriptase in multiple sclerosis patient lymphocytes by inactivated HSV-1, HHV-6 and VZV. J Neuroimmunol. 2007;187(1-2):147-155.  doi: 10.1016/j.jneuroim.2007.04.003
  65. Sanna A, Huang Y, Arru G, Fois M, Link H, Rosati G, Sotgiu S. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Mult Scler. 2008;14(9):1199-1207. doi: 10.1177/1352458508094401
  66. Rizzo R, Gentili V, Casetta I, Caselli E, De Gennaro R, Granieri E, Cassai E, Di Luca D, Rotola A. Altered natural killer cell response to herpes virus infection in multiple sclerosis involves KIR2DL2 expression. J Neuroimmunol. 2012;251(1-2):55-64.  doi: 10.1016/j.jneuroim.2012.07.004
  67. Otto C, Hofmann J, Finke C, Zimmermann M, Ruprecht K. The fraction of varicella zoster virus-specific antibodies among all intrathecally-produced antibodies discriminates between patients with varicella zoster virus reactivation and multiple sclerosis. Fluids Barriers CNS. 2014;11(1):3.  doi: 10.1186/2045-8118-11-3
  68. Ordoñez G, Martinez-Palomo A, Corona T, Pineda B, Flores-Rivera J, Gonzalez A, Chavez-Munguia B, Sotelo J. Varicella zoster virus in progressive forms of multiple sclerosis. Clin Neurol Neurosurg. 2010;112(8):653-657.  doi: 10.1016/j.clineuro.2010.04.018
  69. Sanadgol N, Ramroodi N, Ahmadi G, Komijani M, Moghtaderi A, Bouzari M, Rezaei M, Kardi M, Dabiri S, Moradi M, Sanadgol E. Prevalence of cytomegalovirus infection and its role in total immunoglobulin pattern in Iranian patients with different subtypes of multiple sclerosis. New Microbiol. 2011;34(3):263-274.
  70. Sundqvist E, Bergström T, Daialhosein H, Nyström M, Sundström P, Hillert J, Alfredsson L, Kockum I, Olsson T. Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler. 2014;20(2):165-173.  doi: 10.1177/1352458513494489

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.